Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Rodman & Renshaw Eleventh Annual Healthcare Conference on Thursday September 10, 2009, at 2:50 PM E.T. at The New York Palace Hotel in New York, N.Y.

Back to news